Immunotherapy drug combinations extend kidney cancer survival by years

1 month ago 5

Immunotherapy drug combinations extend kidney cancer survival by years

INDIANAPOLIS (WISH) — Kidney cancer is one of the fastest-growing cancers in the U.S.

Until recently, a diagnosis of advanced disease often meant just a few years to live.

Now, new immunotherapy combinations are helping many patients live from 10-15 years longer than ever before.

Bob Kinkead has always played the numbers; first as a talent manager counting hit songs and now counting the years he’s living with advanced kidney cancer. “I went through a couple years of really just severe pain. I though...

Read Entire Article